PHASE-I STUDY OF CYCLOPHOSPHAMIDE (NSC26271) BY 72-HOUR CONTINUOUS INTRAVENOUS-INFUSION

被引：7
|
作者：
BEDIKIAN, AY [1 ]
BODEY, GP [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT DEV THERAPEUT,HOUSTON,TX 77030
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1983年 / 6卷 / 03期
关键词：
D O I：
10.1097/00000421-198306000-00018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：365 / 368
页数：4
相关论文
共 50 条
  • [31] PHASE-I TRIAL OF CONCURRENT INTRAPERITONEAL AND CONTINUOUS INTRAVENOUS-INFUSION OF FLUOROURACIL IN PATIENTS WITH REFRACTORY CANCER
    REICHMAN, B
    MARKMAN, M
    HAKES, T
    KEMENY, N
    KELSEN, D
    HOSKINS, W
    RUBIN, S
    LEWIS, JL
    JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (01) : 158 - 162
  • [32] PHASE-I CLINICAL-TRIAL OF TAXOTERE ADMINISTERED AS EITHER A 2-HOUR OR 6-HOUR INTRAVENOUS-INFUSION
    BURRIS, H
    IRVIN, R
    KUHN, J
    KALTER, S
    SMITH, L
    SHAFFER, D
    FIELDS, S
    WEISS, G
    ECKARDT, J
    RODRIGUEZ, G
    RINALDI, D
    WALL, J
    COOK, G
    SMITH, S
    VREELAND, F
    BAYSSAS, M
    LEBAIL, N
    VONHOFF, D
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (05) : 950 - 958
  • [33] A PHASE-I TRIAL OF DACTINOMYCIN INTRAVENOUS-INFUSION IN PATIENTS WITH ADVANCED MALIGNANCIES
    BLUMENREICH, MS
    WOODCOCK, TM
    RICHMAN, SP
    JONES, MK
    GENTILE, PS
    KUBOTA, TT
    ALLEGRA, JC
    CANCER, 1985, 56 (02) : 256 - 258
  • [34] Phase I trial of the colloidal dispersion formulation of 9-Amino-20(S)-camptothecin administered as a 72-hour continuous intravenous infusion
    Eder, JP
    Supko, JG
    Lynch, T
    Bryant, M
    Vosburgh, E
    Shulman, LN
    Xu, GX
    Kufe, DW
    CLINICAL CANCER RESEARCH, 1998, 4 (02) : 317 - 324
  • [35] PHASE-I AND PHARMACOKINETIC STUDY OF AMINOPTERIN GIVEN BY INTRAVENOUS-INFUSION WITH CITROVORUM FACTOR RESCUE
    ISRAILI, ZH
    YORK, RM
    MOORE, M
    CUNNINGHAM, RF
    HUGULEY, CM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 186 - 186
  • [36] PHASE-II STUDY OF BISANTRENE ADMINISTERED BY CONTINUOUS 72-HOUR INFUSION FOR ADVANCED PANCREATIC ADENOCARCINOMA
    MARSCHKE, RF
    KVOLS, LK
    CULLINAN, SA
    LAURIE, JA
    MAILLIARD, JA
    TSCHETTER, LK
    OCONNELL, MJ
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (04): : 269 - 270
  • [37] PHASE-I AND PHARMACOLOGIC STUDY OF 72-HOUR INFUSED 5-FLUOROURACIL AND HYPERFRACTIONATED CYCLICAL RADIATION
    BYFIELD, JE
    FRANKEL, SS
    SHARP, TR
    HORNBECK, CL
    CALLIPARI, FB
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1985, 11 (04): : 791 - 800
  • [38] A PHASE-I TRIAL OF BRYOSTATIN 1 IN PATIENTS WITH ADVANCED MALIGNANCY USING A 24-HOUR INTRAVENOUS-INFUSION
    JAYSON, GC
    CROWTHER, D
    PRENDIVILLE, J
    MCGOWN, AT
    SCHEID, C
    STERN, P
    YOUNG, R
    BRENCHLEY, P
    CHANG, J
    OWENS, S
    PETTIT, GR
    BRITISH JOURNAL OF CANCER, 1995, 72 (02) : 461 - 468
  • [39] PHASE-I AND PHARMACOLOGICAL STUDY OF ACIVICIN BY 24-HOUR CONTINUOUS INFUSION
    WEISS, GR
    MCGOVREN, JP
    SCHADE, D
    KUFE, DW
    CANCER RESEARCH, 1982, 42 (09) : 3892 - 3895
  • [40] Phase I trial of the topoisomerase I inhibitor GG211 as a 72-hour infusion
    ODwyer, P
    PasArez, L
    Kunka, R
    DeMaria, D
    Cassidy, J
    Kaye, S
    DePee, S
    Littlefield, D
    Selinger, K
    Beranek, P
    Graham, J
    Wissel, P
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 928 - 928
12345